F/M Investments’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-70,745
Closed -$1.76M 451
2025
Q4
$1.76M Sell
70,745
-1,932
-3% -$51.3K 0.07% 254
2025
Q3
$2.06M Sell
72,677
-540
-0.7% -$14.6K 0.08% 239
2025
Q2
$1.82M Buy
73,217
+102
+0.1% +$2.87K 0.07% 254
2025
Q1
$2.27M Sell
73,115
-1,214
-2% -$40.4K 0.09% 215
2024
Q4
$2.34M Sell
74,329
-128,262
-63% -$6.09M 0.09% 210
2024
Q3
$11.7M Sell
202,591
-910
-0.4% -$44.7K 0.37% 81
2024
Q2
$8.25M Buy
+203,501
New +$8.07M 0.3% 114

Other funds holding ASTH

F/M Investments's ASTH Position: Q1 2026 in Review

F/M Investments sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 70,745 shares — an estimated $1.76M sold.

F/M Investments first reported a position in ASTH in Q2 2024 and held it in 7 quarters. The position peaked at $11.7M in Q3 2024. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • F/M Investments reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
  • F/M Investments sold 70,745 Astrana Health shares in Q1 2026, an estimated $1.76M.
  • F/M Investments first reported a position in Astrana Health in Q2 2024 and held it in 7 quarters.
  • F/M Investments's Astrana Health position peaked at $11.7M in Q3 2024.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.